Gout Prevention — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for gout prevention. 45 active patents protecting 2 drugs from 2+ originators. First major cliff: 2028. Daily refresh.

2
Approved drugs
45
Active US patents
72/100
Avg vulnerability
—
Annual revenue covered

Originators in Gout Prevention

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Scilex Pharms 41 patents Takeda 4 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating gout prevention. Each bar = one year. Y-axis scaled to peak year (17 patents).

11
28
6
29
4
31
17
33
1
34
5
36
1
37

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Colcrys
COLCHICINE
 Scilex Pharms 41 72 — 2028-10-06
Uloric
FEBUXOSTAT
 Takeda 4 71 — 2031-09-08

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8415395 Colcrys method of use 80 2028-10-06
8093297 Colcrys method of use 80 2028-10-06
8093296 Colcrys method of use 80 2028-10-06
8093298 Colcrys method of use 80 2028-10-06
7964648 Colcrys method of use 80 2028-10-06
7981938 Colcrys method of use 80 2028-10-06
7964647 Colcrys method of use 80 2028-10-06
8097655 Colcrys method of use 80 2028-10-06
8415396 Colcrys method of use 80 2028-10-06
7619004 Colcrys method of use 80 2028-12-03

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10226423 Colcrys formulation 42 2037-12-20
9907751 Colcrys formulation 42 2036-11-22
10383821 Colcrys formulation 42 2036-11-22
10383820 Colcrys method of use 62 2036-11-22
9399036 Colcrys method of use 62 2033-08-22
9675613 Colcrys method of use 62 2033-08-22
9789108 Colcrys method of use 62 2033-08-22
8927607 Colcrys method of use 62 2033-08-22
9555029 Colcrys method of use 62 2033-08-22
9107912 Uloric method of use 68 2031-09-08

Related